Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy

Jingrui Chen(Washington State University Spokane), Zhaokang Cheng(Washington State University Spokane)
Cardiovascular Research
April 22, 2024
Cited by 16


Related Papers